To mark the United Nations International Day of Persons with Disabilities, the World Health Organization (WHO) will host a special webinar, Preventing and addressing TB-related disabilities and improving quality of life, on 2 December 2021.

24 November 2021 | Geneva -- The World Health Organization’s (WHO’s) 2021 Model Lists of Essential Medicines feature key updates to the TB section including the addition of moxifloxacin and rifapentine for the indication of drug susceptible TB, child friendly formulations of bedaquiline and delamanid to treat drug resistant TB and a higher dose formulation of rifapentine for TB preventive treatment. Further updates include the addition of other TB medicines to the list as well as the removal of some TB medicines that are no longer considered essential. The revised list provides a comprehensive list of quality assured TB medicines for TB preventive treatment as well as for the treatment of drug susceptible and drug resistant TB. 

The World Health Organization (WHO) Global TB Program is organizing an Information Session for civil society representatives to provide an update on WHO TB guidelines development on 10 December 2021.

In order to increase the knowledge base for normative guidance on optimal treatment modalities for drug-resistant tuberculosis (DR-TB), WHO is announcing a publicly accessible global individual patient data (IPD) platform for drug-resistant tuberculosis treatment (DR-TB-IPD). This will be a secure but accessible platform containing outcomes of over 10,000 drug-resistant TB patients as the starting point and expanding this with data received in response to a recent public call for data.

The World Health Organization issues a new compendium of data and evidence-related tools for use in TB planning and programming.

New Delhi, 26 October 2021-- The Ministers of Health of countries in the World Health Organization (WHO) South-East Asia Region today committed to renew and accelerate efforts to end tuberculosis, in view of the pandemic disrupting services and leading to increase in TB cases in the already high-burden Region. 

The new version of the World Health Organization (WHO) 2021 Global TB Report app is now available for free download in English, French, Spanish and Russian.

TB deaths rise for the first time in more than a decade due to the COVID-19 pandemic.

The World Health Organization (WHO) Global TB Program launched a call for case studies and best practices on the adaptation and implementation of the WHO Multisectoral Accountability Framework on TB (MAF-TB).

27 September 2021 | Geneva: The World Health Organization (WHO) has established a new technical advisory group that will advise on TB diagnostic tools and strategies, and complement the WHO guideline development process.